Home
Conditions
Recurrent Ovarian Carcinoma

Clinical trial condition

Recurrent Ovarian Carcinoma

Explore clinical trials studying Recurrent Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Ovarian Carcinoma trial results

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377

Conditions: Adnexal Diseases, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, +36 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

CTCA at Western Regional Medical Center Goodyear, Arizona, United States

View all 483 locations

View Trial Details

Recruiting

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

NCT04469764

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +21 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

NCT07144826

Conditions: Adnexal Diseases, Advanced Ovarian Carcinoma, Endocrine Gland Neoplasms, +17 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

NCT04055649

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +24 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States

View Trial Details

Recruiting

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT05231122

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

NCT06295965

Conditions: Adnexal Diseases, Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis, +24 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

NCT03604315

Conditions: Adnexal Diseases, Breast Carcinoma, Breast Diseases, +26 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT05920798

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

NCT04919629

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

NCT06483048

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Recurrent Ovarian Carcinoma

Recurrent Ovarian Carcinoma trial results

Related conditions